Oriental Aromat. Q1 FY27 Earnings Call — Analysis (NSE: OAL)
Q1 FY27 revenue up 15% YoY to ₹260 Cr, margins improve sequentially, Mahad facility utilization at 50-60%
The take
Q1FY27 Revenue from Operations (YoY) ₹260 Cr ( +15% YoY ) . New guidance — FY27 consolidated sales growth 10%-15% . New story: Mahad commercialization journey .
Results
Revenue ₹260 Cr +15% YoY; EBITDA margin 7.62% (+71 bps QoQ, -39 bps YoY); PAT ₹2.51 Cr vs ₹0.5 Cr YoY; sales volumes +22% YoY
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Revenue from Operations (YoY) | ₹260 Cr | +15% | yoy · Q1FY27 |
| Revenue from Operations (QoQ) | ₹260 Cr | -8% | qoq · Q1FY27 |
| EBITDA (YoY) | ₹19.8 Cr | +₹1.74 Cr | yoy · Q1FY27 · from ₹18.06 Cr in Q1FY26 |
| EBITDA (QoQ) | ₹19.8 Cr | +₹0.34 Cr | qoq · Q1FY27 · from ₹19.46 Cr in Q4FY26 |
| EBITDA Margin (QoQ) | 7.62% | +71 bps | qoq · Q1FY27 · from 6.89% in Q4FY26 |
| EBITDA Margin (YoY) | 7.62% | -39 bps | yoy · Q1FY27 · from 8.01% in Q1FY26 |
| Profit After Tax (YoY) | ₹2.51 Cr | +₹2.01 Cr | yoy · Q1FY27 · from ₹0.5 Cr in Q1FY26 |
| Profit After Tax (QoQ) | ₹2.51 Cr | -₹1.47 Cr | qoq · Q1FY27 · from ₹3.98 Cr in Q4FY26 |
| Net Debt-to-Equity Ratio | 0.56x | −improved from 0.58x | point_in_time · Jun-26 · as of Jun-26 |
| Export Revenue Share | 35% | +2pp | yoy · Q1FY27 · vs 33% in FY26 |
| Sales Volume Growth (YoY) | 22% | +22% | yoy · Q1FY27 |
Guidance
FY27 revenue growth targeted at 10-15% YoY; Mahad utilization targeted at 75-80% for EBITDA breakeven (no date)
What management committed to
- [Oriental Aromatics] is looking at a trajectory of 10% to 15% growth in sales in the next one year — 10%-15%, FY27
- Progressively move [Mahad] facility towards 75% to 80% utilization, where [management] believe Mahad will become EBITDA positive and begin contributing meaningfully to consolidated profitability — 75-80% utilization, EBITDA positive
- Effective tax rate for [FY27] is around 25% — 25%, FY27
- [Export revenue share] will probably stay in the same range going forward, with no substantial change in the proportion of exports versus local sales — same range (implied ~33-35%), going forward
Key themes
Mahad ramp-up and margin recovery
How the narrative shifted
- Mahad commercialization journey: Mahad seen as a long-term strategic investment with gradual qualification cycle; utilization ramp is key to consolidated profitability, but management avoids committing to a timeline.
- Raw material cost headwinds: Alpha-Pinene up 70-80%, petro-based raw materials volatile; cost pressure persists while competitive pricing limits pass-through; company relies on supplier relationships and tactical buying.
- Fragrance division as value driver: Management emphasizes that backward integration provides a competitive edge for the Fragrance division, enabling growth and margin expansion without new capex; this is framed as the overlooked investment case.
- Camphor overcapacity and import uncertainty: Structural overcapacity in domestic camphor limits upside; no progress on import ban discussion; management realistic about challenging industry dynamics.
- Volume growth vs realization pressure: Strong volume growth (+22%) offset by realizations dip due to raw material hikes and early customer pull-ins; mix shift will remain fluid.
- Capital discipline and asset sweating: Management commits to maximizing existing asset utilization before any major expansionary capex; net debt-to-equity improving.
Operational commentary
- Mahad Specialty Aroma Ingredients facility operating at 50-60% utilization; commercialization and customer qualifications progressing; management targets 75-80% utilization for EBITDA breakeven
- Camphor division volumes surged YoY driven by pre-festive inventory build, but domestic market faces structural overcapacity and intense pricing pressure; key raw material Alpha-Pinene prices up 70-80% over five months
- Specialty Aroma Ingredients segment under pressure from Asian capacity additions; competitive pricing persists while raw material costs remain elevated; company focuses on process re-engineering, yield improvement, and cost optimization
- Fragrance division benefits from backward integration; management highlights its asset-light growth potential and strategic positioning without major capex; likely to drive future margin and mix improvement
- Export contribution steady at 35% of revenue; management expects this proportion to continue
- Net debt-to-equity improved to 0.56x; company prioritizes sweating existing assets over new major expansionary capex
- R&D spend currently ~2-2.5% of sales
- No fresh developments on the earlier discussions with government regarding import ban on camphor
Analyst Q&A
Q. What is the current utilization and peak revenue potential with full utilization?
Mahad at 50-60%, other plants at 85-90%; near-term revenue growth 10-15%; long-term peak numbers deferred to CFO
Q. What proportion of Camphor division comes from in-house brands Saraswati and 3 Pine?
We do not give breakup of individual sub-divisions.
Q. When will Mahad see meaningful scaling and top-line contribution?
As and when it happens, we will be informing the investor community. It takes 500-1,000 days for new products to see light of day.
Q. Given 22% volume growth vs 15% revenue growth, what is the outlook for realizations and volume growth needed for 10-15% revenue target?
Gap driven by raw material price increase and customers taking material early; mix keeps changing; unable to give specific split.
Research and educational content only. Not investment advice.